Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating rituximab with combination chemotherapy for newly diagnosed Waldenström's macroglobulinemia; the study is terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2013-02-12